[Retracted] Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data

Table 1

Clinical baseline data of different concentrations of PROK1 and PROK2.

Characteristic	Low expression of PROK1	High expression of PROK1		Low expression of PROK2	High expression of PROK2
	264	264		264	264
WHO grade			0.047			0.974
G2	123 (26.3%)	101 (21.6%)		111 (23.8%)	113 (24.2%)
G3	110 (23.6%)	133 (28.5%)		119 (25.5%)	124 (26.6%)
Gender			1			0.08
Female	119 (22.5%)	120 (22.7%)		109 (20.6%)	130 (24.6%)
Male	145 (27.5%)	144 (27.3%)		155 (29.4%)	134 (25.4%)
Age, meidan (IQR)	38 (31, 48)	43.5 (33, 55)	< 0.001	41 (33, 50)	39 (31.75, 55.25)	0.613